Also found in: Thesaurus, Medical, Encyclopedia.
Related to angiogenic: angiogenic growth factors


n. pl. an·gi·o·gen·e·ses (-sēz′)
The formation of new blood vessels.

an′gi·o·gen′ic (-jĕn′ĭk) adj.


promoting or relating to blood vessel growth
References in periodicals archive ?
Synthesized 1-monocaproin was found to show the angiogenic effect at a dose concentration equivalent to VEGF at 1,000 ppm.
We have seen angiogenic mechanisms and angiogenic genes in the pathophysiology of nonalcoholic fatty liver disease," said Dr.
Conversely, the key angiogenic factor, vascular endothelial growth factor (VEGF-A, termed from hereon VEGF), as well as other members of its family such as VEGF-C and VEGF-D, and their receptors, are expressed in neuronal cells and participate in processes such as neurogenesis, neuronal migration, axon guidance, dendritogenesis and dendrite maintenance4-10.
However, unregulated angiogenesis would cause angiogenic diseases such as diabetic retinopathy, tumor growth and metastasis, rheumatoid arthritis, and inflammatory diseases.
Previous studies showed that VEGF [sub]165 b was downregulated in angiogenic diseases such as diabetic retinopathy, [sup][4],[8] retinal vein occlusion, and age-related macular degeneration (AMD).
The product has been indicated to inhibit a distinct profile of angiogenic tyrosine kinase targets.
Vascular Endothelial Growth Factor A (VEGF-A) is the most specific and prominent angiogenic factor among all VEGF family members.
In that cancer cells employ the mechanism known as angiogenesis to connect to the body's blood supply, Mridula Chopra and colleagues from the University of Portsmouth (UK) observed that lycopene disabled the angiogenic ability of cancer cells.
Recent exciting work identified novel soluble angiogenic factors that are related to the pathogenesis of the disease (8).
announced publication of a paper describing the angiogenic properties of its cellular therapies.
In the study, there was no association between the level of vitamin D and levels of two angiogenic factors that have been previously implicated in the development of preeclampsia, soluble FMS-like tyrosine kinase 1 (sFlt-1) and placental growth factor (PlGF).
Folkman's suggestion that depriving tumors of oxygen and nutrients would lead to their quiescent state and prevent tumor expansion gave rise to a search for angiogenic inhibitors.